Literature DB >> 25621242

Rhinocerebral mucormycosis: a retrospective study.

Jyoti Shailesh Kolekar1.   

Abstract

Mucormycosis is an acute often fatal infection caused by fungi of family mucoracea (Kauffman and Malani Curr Infect Dis Rep 9(6):435-440). The principal pathogens in this family are rhizopus, mucor and absidia species. Mucoracea are found in soil, decaying vegetation and other organic matter. Mucormycosis is a polymorphic disease with diverse clinical manifestation. It is divided into rhinocerebral, pulmonary, cutaneous, cardiac, gastrointestinal and disseminated. Rhinocerebral mucormycosis the most commonest manifestation of mucormycosis is usually a fatal fulminant infection. Rhinocerebral mucormycosis can be further divided into rhino-maxillary and rhino-orbito-cerebral. The disease commonly occur in diabetics who have ketoacidosis but is also seen in severely debilitated or immunosuppressed patients. It has also been reported from otherwise normal individuals. Early diagnosis and treatment is mandatory for a successful management of this infection.

Entities:  

Keywords:  Amphotericin B; Pathology; Rhinocerebral Mucormycosis; Treatment

Year:  2014        PMID: 25621242      PMCID: PMC4298568          DOI: 10.1007/s12070-014-0804-5

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  18 in total

1.  Mucormycosis: necrotizing soft tissue lesion of the face.

Authors:  Christoph Leitner; Jürgen Hoffmann; Martin Zerfowski; Siegmar Reinert
Journal:  J Oral Maxillofac Surg       Date:  2003-11       Impact factor: 1.895

2.  Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).

Authors:  Thomas J Walsh; Maria N Gamaletsou; Michael R McGinnis; Randall T Hayden; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 3.  Long-term survival in rhinocerebral mucormycosis. Case report.

Authors:  B E Weprin; W A Hall; J Goodman; G L Adams
Journal:  J Neurosurg       Date:  1998-03       Impact factor: 5.115

Review 4.  Serious infections in elderly patients with diabetes mellitus.

Authors:  Shobita Rajagopalan
Journal:  Clin Infect Dis       Date:  2005-02-24       Impact factor: 9.079

5.  Slowly progressive cutaneous, rhinofacial, and pulmonary mucormycosis caused by Mucor irregularis in an immunocompetent woman.

Authors:  Zhi-Kuan Xia; Wen-Ling Wang; Rong-Ya Yang
Journal:  Clin Infect Dis       Date:  2012-12-14       Impact factor: 9.079

Review 6.  Chronic rhinocerebral mucormycosis.

Authors:  W C Harrill; M G Stewart; A G Lee; P Cernoch
Journal:  Laryngoscope       Date:  1996-10       Impact factor: 3.325

7.  Mucormycosis after kidney transplantations: report of seven cases.

Authors:  Jafar Aslani; Morteza Eizadi; Babak Kardavani; Hamid-Reza Khoddami-Vishteh; Eghlim Nemati; Seyed Mohammad Javad Hoseini; Behzad Einollahi
Journal:  Scand J Infect Dis       Date:  2007

Review 8.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

9.  Rhinocerebral mucormycosis: predisposing factors.

Authors:  J S McNulty
Journal:  Laryngoscope       Date:  1982-10       Impact factor: 3.325

View more
  11 in total

1.  Acute invasive fungal rhinosinusitis: our 2 year experience and outcome analysis.

Authors:  Raghunath Shanbag; Nita Rachel Rajan; Arun Kumar
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-22       Impact factor: 2.503

2.  Early Diagnosis and Surgery is Crucial to Survival Outcome in Rhinocerebral Mucormycosis.

Authors:  Devi Dayal; Jaimanti Bakshi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-01-07

Review 3.  Fungal infections in pediatric neurosurgery.

Authors:  Adrian Caceres; Maria Luisa Avila; Marco Luis Herrera
Journal:  Childs Nerv Syst       Date:  2018-08-18       Impact factor: 1.475

4.  Rhinocerebral Mucormycosis in a COVID-19 Patient from Nepal: A Case Report.

Authors:  Sanjay Kumar Gupta; Pallawi Jyotsana; Avilasha Singh; Diwakar Phuyal; Parbej Allam
Journal:  JNMA J Nepal Med Assoc       Date:  2021-07-30       Impact factor: 0.556

5.  Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.

Authors:  Mohammadreza Salehi; Farhad Shahi; Fatema Sadaat Rizvi; Sara Ghaderkhani; Hamed Zainaldain; Sadegh Khodavaisy; Saeed Reza Jamali-Moghaddam; Seyed Ali Dehghan Manshadi; Omid Rezahosseini
Journal:  Caspian J Intern Med       Date:  2020

6.  Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.

Authors:  Satya Prakash Singh; Jagriti Rana; Vinod Kumar Singh; Rupanshi Singh; Reena Sachan; Shivangi Singh; Sachin Jain
Journal:  Rom J Ophthalmol       Date:  2021 Oct-Dec

7.  Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis.

Authors:  Harun Gür; Onur İsmi; Yusuf Vayısoğlu; Kemal Görür; Rabia Bozdoğan Arpacı; Elif Şahin Horasan; Cengiz Özcan
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-01       Impact factor: 2.503

Review 8.  An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis.

Authors:  Sheri K Palejwala; Tirdad T Zangeneh; Stephen A Goldstein; G Michael Lemole
Journal:  Surg Neurol Int       Date:  2016-05-25

Review 9.  Epidemiology of Mucormycosis in India.

Authors:  Hariprasath Prakash; Arunaloke Chakrabarti
Journal:  Microorganisms       Date:  2021-03-04

Review 10.  Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes.

Authors:  Omer Sefvan Janjua; Muhammad Saad Shaikh; Muhammad Amber Fareed; Sana Mehmood Qureshi; Muhammad Ikram Khan; Danya Hashem; Muhammad Sohail Zafar
Journal:  J Fungi (Basel)       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.